Related Experiment Video
Updated: May 18, 2026

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Type 2 diabetes--a heterogeneous disease with a foetal predisposition]
1Medicinsk Endokrinologisk Klinik, Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark. allan.vaag@rh.regionh.dk
Ugeskrift for Laeger
|September 14, 2012
Summary
Adverse intrauterine environments, not genetics, may drive type 2 diabetes (T2D) propagation. Low birthweight can impair adipose tissue expansion, leading to T2D via lipotoxicity.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Developmental Origins of Health and Disease (DOHaD)
Background:
- Type 2 Diabetes (T2D) is a complex metabolic disorder with multifactorial origins.
- While genetic factors play a role, they explain only a small proportion of T2D cases.
- The intrauterine environment's influence on T2D development is increasingly recognized.
Purpose of the Study:
- To investigate the role of the intrauterine environment in the global rise of Type 2 Diabetes.
- To explore the link between low birthweight, impaired adipose tissue expansion, and T2D pathogenesis.
- To highlight potential future strategies for T2D prevention and personalized treatment.
Main Methods:
- This study synthesizes existing research on T2D etiology, focusing on environmental factors during gestation.
- It examines the physiological consequences of impaired subcutaneous adipose tissue expandability.
- The analysis connects low birthweight to lipotoxicity in non-adipose tissues.
Main Results:
- Adverse intrauterine conditions are a significant driver of Type 2 Diabetes.
- Low birthweight is associated with reduced subcutaneous adipose tissue expandability.
- This impairment can lead to ectopic fat deposition and lipotoxicity, contributing to T2D.
Conclusions:
- The intrauterine environment plays a critical role in the propagation of Type 2 Diabetes.
- Strategies focusing on maternal health and fetal development are crucial for T2D prevention.
- Personalized treatment approaches for T2D patients may need to consider developmental origins.
Related Concept Videos
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

